Literature DB >> 201452

Potent inhibitory activity of [D-Leu6, Des-Gly-NH2(10)]LHRH ethylamide on LH/hCG and PRL testicular receptor levels in the rat.

C Auclair, P A Kelly, D H Coy, A V Schally, F Labrie.   

Abstract

Injection of male rats with 40-200 ng of [D-Leu6, des-Gly-NH2(10)]LHRH ethylamide for 7 days caused a maximal 80% reduction of testicular LH/hCG receptor level with one injection per day being as efficient as 3 daily injections. A similar inhibitory effect was observed on testicular PRL receptors. Testis and seminal vesicle weight as well as plasma testosterone levels were also significantly reduced by this treatment. These data indicate that a LHRH agonist, when given at a relatively low dose, is capable of reducing testicular LH/hCG and PRL receptor levels as well as testicular function, the effect being probably mediated by increased endogenous gonadotropin secretion.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 201452     DOI: 10.1210/endo-101-6-1890

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  Regulation of primate testicular luteinizing hormone receptors and steroidogenesis.

Authors:  T F Davies; G D Hodgen; M L Dufau; K J Catt
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

2.  Long-acting delivery systems for peptides: inhibition of rat prostate tumors by controlled release of [D-Trp6]luteinizing hormone-releasing hormone from injectable microcapsules.

Authors:  T W Redding; A V Schally; T R Tice; W E Meyers
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

3.  Direct inhibition of testicular function by gonadotropin-releasing hormone: mediation by specific gonadotropin-releasing hormone receptors in interstitial cells.

Authors:  R N Clayton; M Katikineni; V Chan; M L Dufau; K J Catt
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

4.  Inhibition of the growth of some hormone dependent tumors by D-Trp6-LH-RH.

Authors:  A V Schally; T W Redding; A M Comaru-Schally
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

5.  Effects of the duration of therapy with the LHRH agonist D-ser (BUT)6 Azgly10-LHRH (ICI 118-630) on the steroid hormone content and the morphology of human testicular tissue in the treatment of patients with advanced prostate cancer.

Authors:  W Kuber; G Viehberger; R Zeillinger; J Spona
Journal:  Urol Res       Date:  1991
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.